KHTRF Stock: Knight Therapeutics Inc. Stock Price, Analysis & Insights
Get live KHTRF stock price $6.59, comprehensive Knight Therapeutics Inc. stock analysis, charts, news, and expert forecast. Real-time KHTRF stock data and investment insights.
Loading chart data...
Knight Therapeutics Inc. (KHTRF) Overview
Knight Therapeutics Inc. (KHTRF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, KHTRF trades at $6.59 with a market capitalization of 646.05M . Over the past 52 weeks, KHTRF has traded between $4.07 and $6.59 , with the current price positioned at approximately 100% of this ran...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 646.05M
- Current price: $6.59
- 52-week range: $4.07 - $6.59
- P/E ratio: 164.75
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Knight Therapeutics Inc. operates as a specialized pharmaceutical enterprise, actively engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of a broad spectrum of pharmaceutical goods, consumer health solu...
Company Information
- CEO
- Samira Sakhia
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 745
Contact Information
- Website
- https://www.gud-knight.com
- Address
- 3400 De Maisonneuve Boulevard West
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 164.8)
✓ Lower volatility stock (Beta: 0.07) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Knight Therapeutics Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Knight Therapeutics Inc.
- ⚠Investors should consider how Knight Therapeutics Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 164.8) requires strong growth to justify
Market Cap
646.05M
P/E Ratio (TTM)
164.75
Beta
0.07
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare KHTRF with peer companies:
- Price
- $0.13
- Market cap
- 655.46M
- Price
- $1.00
- Market cap
- 437.41M
- Price
- $3.29
- Market cap
- 216.40M
- Price
- $61.16
- Market cap
- 365.45M
- Price
- $0.89
- Market cap
- 315.23M
- Price
- $0.43
- Market cap
- 430.90M
- Price
- $1.86
- Market cap
- 453.24M
- Price
- $4.00
- Market cap
- 204.10M
- Price
- $5.13
- Market cap
- 324.40M
- Price
- $1.30
- Market cap
- 470.36M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.